Ratings changes for Netflix, Kratos Defense & Security Solutions, CoreWeave, Blaize, Cass Information Systems, United Airlines, 1stdibs.com and more…Text “MarketBeat” to 68285 to get SMS breaking news alerts for stocks on your watchlist and other special reports. Learn More.
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.”
Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.
$227.58 +1.45 (+0.64%) As of 7/21/2025 10:06 AM ET
Amazon.com (NASDAQ:AMZN) had its price target raised by Robert W. Baird () (analyst Colin Sebastian) from $220.00 to $244.00. They now have an “outperform” rating on the stock. This represents a 7.9% upside from the current price of $226.13.
$511.29 +1.24 (+0.24%) As of 7/21/2025 10:06 AM ET
Microsoft (NASDAQ:MSFT) had its price target raised by Barclays PLC () (analyst Raimo Lenschow) from $494.00 to $550.00. They now have an “overweight” rating on the stock. This represents a 7.4% upside from the current price of $511.93.
Aveanna Healthcare (NASDAQ:AVAH) was upgraded by analysts at Jefferies Financial Group Inc. from a “hold” rating to a “buy” rating. They now have a $6.00 price target on the stock, down previously from $6.25. This represents a 41.8% upside from the current price of $4.23.
Blaize (NASDAQ:BZAI) was upgraded by analysts at Rosenblatt Securities from a “neutral” rating to a “buy” rating. They now have a $6.00 price target on the stock, up previously from $3.00. This represents a 14.3% upside from the current price of $5.25.
CSX (NASDAQ:CSX) was upgraded by analysts at TD Cowen from a “hold” rating to a “buy” rating. They now have a $45.00 price target on the stock, up previously from $32.00. This represents a 30.2% upside from the current price of $34.57.
Dollar Tree (NASDAQ:DLTR) was upgraded by analysts at Barclays PLC from an “equal weight” rating to an “overweight” rating. They now have a $138.00 price target on the stock, up previously from $95.00. This represents a 23.6% upside from the current price of $111.70.
Etsy (NASDAQ:ETSY) was upgraded by analysts at Morgan Stanley from an “underweight” rating to an “equal weight” rating. They now have a $50.00 price target on the stock, up previously from $38.00. This represents a 17.4% downside from the current price of $60.55.
Fiserv (NYSE:FI) was upgraded by analysts at Monness Crespi & Hardt from a “sell” rating to a “neutral” rating.The current price is $165.92.
Fortis (NYSE:FTS) was upgraded by analysts at CIBC from a “neutral” rating to a “sector outperform” rating.The current price is $47.85.
Globant (NYSE:GLOB) was upgraded by analysts at Scotiabank from a “sector perform” rating to a “sector outperform” rating. They now have a $115.00 price target on the stock. This represents a 32.8% upside from the current price of $86.60.
Invesco (NYSE:IVZ) was upgraded by analysts at TD Cowen from a “hold” rating to a “buy” rating. They now have a $25.00 price target on the stock, up previously from $17.50. This represents a 23.4% upside from the current price of $20.25.
Keysight Technologies (NYSE:KEYS) was upgraded by analysts at Bank of America Corporation from an “underperform” rating to a “neutral” rating. They now have a $175.00 price target on the stock, up previously from $170.00. This represents a 6.9% upside from the current price of $163.78.
Norfolk Southern (NYSE:NSC) was upgraded by analysts at TD Cowen from a “hold” rating to a “buy” rating. They now have a $323.00 price target on the stock, up previously from $263.00. This represents a 16.3% upside from the current price of $277.81.
Pinterest (NYSE:PINS) was upgraded by analysts at Morgan Stanley from an “equal weight” rating to an “overweight” rating. They now have a $45.00 price target on the stock, up previously from $37.00. This represents a 18.1% upside from the current price of $38.10.
American Express (NYSE:AXP) was downgraded by analysts at DZ Bank AG from a “hold” rating to a “sell” rating.The current price is $305.65.
Krispy Kreme (NASDAQ:DNUT) was downgraded by analysts at BNP Paribas Exane from an “outperform” rating to a “neutral” rating. They now have a $3.50 price target on the stock. This represents a 11.6% upside from the current price of $3.14.
Elevance Health (NYSE:ELV) was downgraded by analysts at Argus from a “buy” rating to a “hold” rating.The current price is $279.44.
Gaming and Leisure Properties (NASDAQ:GLPI) was downgraded by analysts at Stifel Nicolaus from a “buy” rating to a “hold” rating. They now have a $51.25 price target on the stock. This represents a 8.8% upside from the current price of $47.12.
Sarepta Therapeutics (NASDAQ:SRPT) was downgraded by analysts at Mizuho from an “outperform” rating to a “neutral” rating. They now have a $14.00 price target on the stock. This represents a 3.7% upside from the current price of $13.51.
Sarepta Therapeutics (NASDAQ:SRPT) was downgraded by analysts at Leerink Partners from an “outperform” rating to a “market perform” rating. They now have a $10.00 price target on the stock. This represents a 26.0% downside from the current price of $13.51.
Sarepta Therapeutics (NASDAQ:SRPT) was downgraded by analysts at Deutsche Bank Aktiengesellschaft from a “buy” rating to a “hold” rating. They now have a $9.00 price target on the stock. This represents a 33.4% downside from the current price of $13.51.
Telus Digital (NYSE:TIXT) was downgraded by analysts at National Bank Financial from an “outperform” rating to a “sector perform” rating. They now have a $4.00 price target on the stock. This represents a 0.1% downside from the current price of $4.01.
Ternium (NYSE:TX) was downgraded by analysts at Morgan Stanley from an “overweight” rating to an “equal weight” rating. They now have a $34.00 price target on the stock. This represents a 10.9% upside from the current price of $30.65.
Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla’s labs.
One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.
Albertsons Companies (NYSE:ACI) is now covered by analysts at Barclays PLC. They set an “underweight” rating and a $19.00 price target on the stock. This represents a 6.8% downside from the current price of $20.39.
Autodesk (NASDAQ:ADSK) is now covered by analysts at Loop Capital. They set a “hold” rating and a $320.00 price target on the stock. This represents a 7.2% upside from the current price of $298.56.
Argan (NYSE:AGX) is now covered by analysts at JPMorgan Chase & Co.. They set a “neutral” rating and a $220.00 price target on the stock. This represents a 5.9% upside from the current price of $207.80.
Alnylam Pharmaceuticals (NASDAQ:ALNY) is now covered by analysts at Truist Financial Corporation. They set a “buy” rating and a $385.00 price target on the stock. This represents a 18.3% upside from the current price of $325.41.
AvePoint (NASDAQ:AVPT) is now covered by analysts at Jefferies Financial Group Inc.. They set a “buy” rating and a $22.00 price target on the stock. This represents a 14.4% upside from the current price of $19.24.
BridgeBio Pharma (NASDAQ:BBIO) is now covered by analysts at Truist Financial Corporation. They set a “buy” rating and a $66.00 price target on the stock. This represents a 40.0% upside from the current price of $47.13.
Colliers International Group (NASDAQ:CIGI) (TSE:CIGI) is now covered by analysts at JMP Securities. They set a “market perform” rating on the stock.The current price is $139.51.
Colliers International Group (NASDAQ:CIGI) (TSE:CIGI) is now covered by analysts at Citizens Jmp. They set a “market perform” rating on the stock.The current price is $139.51.
Centessa Pharmaceuticals (NASDAQ:CNTA) is now covered by analysts at Truist Financial Corporation. They set a “buy” rating and a $30.00 price target on the stock. This represents a 87.3% upside from the current price of $16.02.
Cushman & Wakefield (NYSE:CWK) is now covered by analysts at Citizens Jmp. They set an “outperform” rating and a $15.00 price target on the stock. This represents a 30.2% upside from the current price of $11.52.
Cushman & Wakefield (NYSE:CWK) is now covered by analysts at JMP Securities. They set a “market outperform” rating and a $15.00 price target on the stock. This represents a 30.2% upside from the current price of $11.52.
eMagin (NYSE:EMA) is now covered by analysts at Bank of America Corporation. They set a “buy” rating and a $49.00 price target on the stock. This represents a 7.3% upside from the current price of $45.66.
Harmony Biosciences (NASDAQ:HRMY) is now covered by analysts at Truist Financial Corporation. They set a “buy” rating and a $48.00 price target on the stock. This represents a 33.6% upside from the current price of $35.93.
Disc Medicine (NASDAQ:IRON) is now covered by analysts at Truist Financial Corporation. They set a “buy” rating and a $86.00 price target on the stock. This represents a 46.7% upside from the current price of $58.63.
Jernigan Capital (NYSE:JCAP) is now covered by analysts at JMP Securities. They set a “market outperform” rating and a $23.00 price target on the stock. This represents a 37.7% upside from the current price of $16.70.
Jernigan Capital (NYSE:JCAP) is now covered by analysts at Keefe, Bruyette & Woods. They set an “outperform” rating and a $22.00 price target on the stock. This represents a 31.7% upside from the current price of $16.70.
Jernigan Capital (NYSE:JCAP) is now covered by analysts at Truist Financial Corporation. They set a “buy” rating and a $24.00 price target on the stock. This represents a 43.7% upside from the current price of $16.70.
Jernigan Capital (NYSE:JCAP) is now covered by analysts at Raymond James Financial, Inc.. They set an “outperform” rating and a $19.00 price target on the stock. This represents a 13.8% upside from the current price of $16.70.
Jernigan Capital (NYSE:JCAP) is now covered by analysts at Citizens Jmp. They set an “outperform” rating and a $23.00 price target on the stock. This represents a 37.7% upside from the current price of $16.70.
Jernigan Capital (NYSE:JCAP) is now covered by analysts at Jefferies Financial Group Inc.. They set a “buy” rating and a $29.00 price target on the stock. This represents a 73.7% upside from the current price of $16.70.
Jones Lang LaSalle (NYSE:JLL) is now covered by analysts at Citizens Jmp. They set a “market perform” rating on the stock.The current price is $255.97.
Jones Lang LaSalle (NYSE:JLL) is now covered by analysts at JMP Securities. They set a “market perform” rating on the stock.The current price is $255.97.
John Marshall Bancorp (NASDAQ:JMSB) is now covered by analysts at Keefe, Bruyette & Woods. They set an “outperform” rating and a $22.00 price target on the stock. This represents a 13.3% upside from the current price of $19.43.
Kroger (NYSE:KR) is now covered by analysts at Barclays PLC. They set an “equal weight” rating and a $75.00 price target on the stock. This represents a 4.6% upside from the current price of $71.72.
Centrus Energy (NYSE:LEU) is now covered by analysts at UBS Group AG. They set a “neutral” rating and a $215.00 price target on the stock. This represents a 12.6% downside from the current price of $246.00.
Marcus & Millichap (NYSE:MMI) is now covered by analysts at JMP Securities. They set a “market perform” rating on the stock.The current price is $30.98.
Marcus & Millichap (NYSE:MMI) is now covered by analysts at Citizens Jmp. They set a “market perform” rating on the stock.The current price is $30.98.
Neurocrine Biosciences (NASDAQ:NBIX) is now covered by analysts at Truist Financial Corporation. They set a “buy” rating and a $163.00 price target on the stock. This represents a 22.7% upside from the current price of $132.83.
Newmark Group (NASDAQ:NMRK) is now covered by analysts at Citizens Jmp. They set an “outperform” rating and a $17.00 price target on the stock. This represents a 34.6% upside from the current price of $12.63.
Newmark Group (NASDAQ:NMRK) is now covered by analysts at JMP Securities. They set a “market outperform” rating and a $17.00 price target on the stock. This represents a 34.6% upside from the current price of $12.63.
Park National (NYSE:PRK) is now covered by analysts at Raymond James Financial, Inc.. They set a “market perform” rating on the stock.The current price is $171.76.
Palvella Therapeutics (NASDAQ:PVLA) is now covered by analysts at Truist Financial Corporation. They set a “buy” rating and a $56.00 price target on the stock. This represents a 84.8% upside from the current price of $30.30.
QXO (NASDAQ:QXO) is now covered by analysts at Royal Bank Of Canada. They set an “outperform” rating and a $33.00 price target on the stock. This represents a 49.8% upside from the current price of $22.04.
Radiopharm Theranostics (NASDAQ:RADX) is now covered by analysts at Brookline Capital Management. They set a “buy” rating and a $18.00 price target on the stock. This represents a 304.5% upside from the current price of $4.45.
Ralliant (NYSE:RAL) is now covered by analysts at Citigroup Inc.. They set a “neutral” rating and a $53.00 price target on the stock. This represents a 12.4% upside from the current price of $47.16.
Sprouts Farmers Market (NASDAQ:SFM) is now covered by analysts at Barclays PLC. They set an “equal weight” rating and a $173.00 price target on the stock. This represents a 4.8% upside from the current price of $165.03.
SiriusPoint (NYSE:SPNT) is now covered by analysts at B. Riley. They set a “buy” rating and a $33.00 price target on the stock. This represents a 71.0% upside from the current price of $19.30.
Sportradar Group (NASDAQ:SRAD) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a “neutral” rating and a $31.00 price target on the stock. This represents a 3.8% upside from the current price of $29.87.
Tectonic Therapeutic (NASDAQ:TECX) is now covered by analysts at Truist Financial Corporation. They set a “buy” rating and a $64.00 price target on the stock. This represents a 176.7% upside from the current price of $23.13.
Tenaris (NYSE:TS) is now covered by analysts at Sanford C. Bernstein. They set an “outperform” rating on the stock.The current price is $37.23.
Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis.